Search
for
Sort by
Research 451–480 of 1000+
- Hair Follicle Reconstruction and Stem Cells
- Current and future pharmacotherapy for alopecia areata
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Pharmacological Treatment of Alopecia
- Alopecia Areata
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Alopecia Areata: Current Review
- Free Papers Medical and Surgical: Hair and Nails
- Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Ritlecitinib: First Approval
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?